• Home
• Responsibility
• Corporate responsibility at GSK
• Business case for corporate responsibility

Corporate Responsibility Report 2008

Business case for corporate responsibility

Demonstrating that our practices are responsible and ethical benefits the business in the following ways:

• An improved reputation and greater trust in GSK products
• The ability to attract, retain and motivate talented people. This is becoming increasingly important as fewer young people in our major markets choose science-based careers
• Constructive engagement with stakeholders. This helps us to prevent avoidable conflict and identify innovative approaches that benefit GSK and wider society
• Greater access to markets and the ability to influence healthcare policy through improved relationships with regulators and healthcare payers. Helping governments to increase access to medicines and resolve healthcare challenges is particularly important
• Greater ability to anticipate and prepare for legislative changes and maintain a competitive advantage
• Helping to maintain support for the intellectual property system by finding innovative ways to increase access to medicines
• Reduced costs and more efficient use of resources through increased environmental efficiency

Our business strategy

Our business performance and development are driven by three strategic priorities which are supported by our corporate responsibility activities.

We believe that corporate responsibility should be managed as part of our overall business strategy and through our day-to-day business operations. For this reason we do not have a separate corporate responsibility strategy at GSK.

Corporate responsibility and our strategic priorities

• Back to top